ATLASFennec Pharmaceuticals (FENC) earnings date: Nov 12, 2026
Fennec Pharmaceuticals (FENC) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, before the open. Analysts expect EPS of $0.09.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on FENC
| Last price | $10.24 (-6.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.9% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Fennec Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Fennec Pharmaceuticals reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Fennec Pharmaceuticals. You can switch it off at any time.
Alert me before FENC reportsFree to start. Creating an account takes under a minute.
FENC earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.09 |
| Last report | Aug 11, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -11.9% |
| Average move around a report | ±18.4% (last 4) |
| Sector | Healthcare · Biotechnology |
Fennec Pharmaceuticals earnings history: last 4 reports
Fennec Pharmaceuticals last reported on Aug 11, 2026: EPS of $0.05 against an estimate of $0.02 (+150.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | $0.02 | $0.05 | +150.0% | Beat | +8.1% |
| May 14, 2026 | -$0.02 | $0.01 | +150.0% | Beat | +44.0% |
| Mar 24, 2026 | $0.04 | -$0.10 | -350.0% | Miss | -17.2% |
| Feb 2, 2026 | $0.85 | $0.87 | +2.4% | Beat | +4.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for FENC
See the fair value, the probability range and the earnings history of Fennec Pharmaceuticals on its ATLAS page.
Fennec Pharmaceuticals (FENC) stock analysisPlans from €3.99 a month.
Fennec Pharmaceuticals earnings: frequently asked questions
When does Fennec Pharmaceuticals (FENC) report earnings?
Fennec Pharmaceuticals is scheduled to report on Thursday, November 12, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for FENC?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.09 per share (USD). Estimates can change before the report.
How often does FENC beat earnings estimates?
Of its last 4 reports with a recorded result, Fennec Pharmaceuticals beat the EPS estimate 3 times; the average surprise was -11.9%. Past results do not predict the next one.
How much does FENC move around earnings?
Over its last 4 reports the stock moved an average of 18.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Fennec Pharmaceuticals beat earnings estimates last quarter?
Fennec Pharmaceuticals last reported on Aug 11, 2026: EPS of $0.05 against an estimate of $0.02 (+150.0% surprise), a beat.
How much does FENC usually move in a day?
On a normal trading day the ATLAS model puts FENC’s one-day range at about ±2.9%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer